These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 2780777)
21. Intermittent and continuous cocaine administration: residual behavioral states during withdrawal. King GR; Joyner C; Lee T; Kuhn C; Ellinwood EH Pharmacol Biochem Behav; 1992 Sep; 43(1):243-8. PubMed ID: 1409810 [TBL] [Abstract][Full Text] [Related]
22. Sites of action of ondansetron to inhibit withdrawal from drugs of abuse. Costall B; Jones BJ; Kelly ME; Naylor RJ; Onaivi ES; Tyers MB Pharmacol Biochem Behav; 1990 May; 36(1):97-104. PubMed ID: 2140900 [TBL] [Abstract][Full Text] [Related]
23. Anxiogenic action of acute but not repeated cocaine administration in handling-habituated mice in the plus-maze test. Rogerio R; Takahashi RN Braz J Med Biol Res; 1992; 25(7):713-6. PubMed ID: 1342602 [TBL] [Abstract][Full Text] [Related]
24. Effects of nicotine and a cannabinoid receptor agonist on negative contrast: distinction between anxiety and disappointment? Genn RF; Tucci S; Parikh S; File SE Psychopharmacology (Berl); 2004 Dec; 177(1-2):93-9. PubMed ID: 15205871 [TBL] [Abstract][Full Text] [Related]
30. Brain corticotropin-releasing factor mediates 'anxiety-like' behavior induced by cocaine withdrawal in rats. Sarnyai Z; Bíró E; Gardi J; Vecsernyés M; Julesz J; Telegdy G Brain Res; 1995 Mar; 675(1-2):89-97. PubMed ID: 7796157 [TBL] [Abstract][Full Text] [Related]
31. Anxiogenic effects of acute and chronic cocaine administration: neurochemical and behavioral studies. Yang XM; Gorman AL; Dunn AJ; Goeders NE Pharmacol Biochem Behav; 1992 Mar; 41(3):643-50. PubMed ID: 1584846 [TBL] [Abstract][Full Text] [Related]
32. Effects of buspirone on the immediate positive and delayed negative properties of intravenous cocaine as measured in the conditioned place preference test. Ettenberg A; Bernardi RE Pharmacol Biochem Behav; 2007 May; 87(1):171-8. PubMed ID: 17524462 [TBL] [Abstract][Full Text] [Related]
33. Neuroanatomical sites of action of 5-HT3 receptor agonist and antagonists for alteration of aversive behaviour in the mouse. Costall B; Kelly ME; Naylor RJ; Onaivi ES; Tyers MB Br J Pharmacol; 1989 Feb; 96(2):325-32. PubMed ID: 2522335 [TBL] [Abstract][Full Text] [Related]
34. Anxiolytic-like and anxiogenic-like effects of nicotine are regulated via diverse action at β2*nicotinic acetylcholine receptors. Anderson SM; Brunzell DH Br J Pharmacol; 2015 Jun; 172(11):2864-77. PubMed ID: 25625469 [TBL] [Abstract][Full Text] [Related]
35. Effects of acute and chronic nicotine on elevated plus maze in mice: involvement of calcium channels. Biala G; Budzynska B Life Sci; 2006 May; 79(1):81-8. PubMed ID: 16458932 [TBL] [Abstract][Full Text] [Related]
36. Behavioural consequences of cocaine withdrawal in rats. Fung YK; Richard LA J Pharm Pharmacol; 1994 Feb; 46(2):150-2. PubMed ID: 8021807 [TBL] [Abstract][Full Text] [Related]
37. Clozapine and cocaine effects on dopamine and serotonin release in nucleus accumbens during psychostimulant behavior and withdrawal. Broderick PA; Hope O; Okonji C; Rahni DN; Zhou Y Prog Neuropsychopharmacol Biol Psychiatry; 2004 Jan; 28(1):157-71. PubMed ID: 14687870 [TBL] [Abstract][Full Text] [Related]
38. Nicotine place preference in a biased conditioned place preference design. Brielmaier JM; McDonald CG; Smith RF Pharmacol Biochem Behav; 2008 Mar; 89(1):94-100. PubMed ID: 18086490 [TBL] [Abstract][Full Text] [Related]